Ozonation of NSAID: A Biodegradability and Toxicity Study

Ozone: Science and Engineering

Volumn 32, Issue 2, 2010, Pages 91-98

  Coelho, Alessandra D ^a,b   Sans, Carmen ^b   Esplugas, Santiago ^b   Dezotti, Márcia ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Biodegradability; Diclofenac; Ibuprofen; Naproxen; NSAID; Ozone; Toxicity

Indexed keywords

DICLOFENAC; IBUPROFEN; NAPROXEN; NAPROXENS; NSAID;

BIOCOMPATIBILITY; BIODEGRADATION; BIOLOGICAL WATER TREATMENT; BIOMINERALIZATION; EFFLUENTS; OZONE WATER TREATMENT; OZONIZATION; TESTING; TOXICITY; WASTEWATER; WASTEWATER TREATMENT;

OZONE;

EID: 77951066047     PISSN: 01919512     EISSN: 15476545     Source Type: Journal    
DOI: 10.1080/01919510903508162     Document Type: Article

References (38)

1. Beltran, F.J., J.F. Garcia-Ara ya, and P.M. Alvarez, "Sodium Dodecylbenzenesulfonate Removal from Water and Wastewater. 2. Kinetics of the Integrated Ozone-Activated Sludge System", Ind. Eng. Chem. Res., 39:2221-2227 (2000).
2. Bendz, D., N.A. Paxeus, T.R. Ginn, and F. Loge, "Occurrence and Fate of Pharmaceutically Active Compounds in the Environmental, A Case Study: Hoje River in Sweden", J. Hazard. Mater., 122:195-204 (2005).
3. Calza, P., V.A. Sakkas, C. Medana, C. Baiocchi, A. Dimou, E. Pellizetti, and T. Albanis, "Photocatalytic Degradation Study of Diclofenac over Aqueous TiO2 Suspensions:, Appl. Catal.: B Environ., 67:197-205 (2006).
4. Camel, V. and A. Bermond, The Use of Ozone and Associated Oxidation Processes in Drinking Water Treatment. Water Res., 32:3208-3222 (1998).
5. Cleuvers, M., Mixture Toxicity of the Anti-inflammatory Drugs Diclofenac, Ibuprofen, Naproxen, and Acetylsalicylic Acid", Ecotoxicol. Environ. Saf., 59:309-315 (2004).
6. Contreras, S., M. Rodriguez, F. Al Momani, C. Sans, and S. Esplugas, "Contribution of the Ozonation Pre-treatment to the Biodegradation of Aqueous Solution of 2,4-dichlorophenol", Water Res., 37:3164-3171 (2003).
7. Dantas, R.F., S. Contreras, C. Sans, and S. Esplugas, "Sulfamethoxazole Abatement by Means of Ozonation", J. Hazard. Mater., 150:790-794 (2008).
8. Dietrich, D.R., S.F. Webb, and T. Petry, "Hot Spot Pollutants: Pharmaceuticals in the Environment", Toxicol. Lett., 131:1-3 (2002).
9. Esplugas, S., D.M. Bila, L.G.T. Krause, M. Dezotti, "Ozonation and Advanced Oxidation Technologies to Remove Endocrine Disrupting Chemicals (EDCs) and Pharmaceuticals and Personal Care Products (PPCPs) in Water Effluents", J. Hazard. Mater., 149:631-642 (2007).
10. Esplugas, S., S. Contreras and D.F. Ollis, "Engineering Aspects of the Integration of Chemical and Biological Oxidation: Simple Mechanistic Models for the Oxidation Treatment", J. Environ. Eng., 130:967-974 (2004).
11. Gobel, A., A. Thomsen, C.S. Mcardell, A. Joss and W. Giger, "Occurrence and Sorption Behavior of Sulfonamides, Macrolides, and Trimethoprim in Activated Sludge Treatment", Environ. Sci. Technol., 39:3981-3989 (2005).
12. Heberer, T., "Occurrence, Fate, and Removal of Pharmaceutical Residues in the Aquatic Environment: A Review of Recent Research Data", Toxicol. Lett., 131:5-17 (2002).
13. Hirsch, R., T.A. Ternes, K. Haberer and K.L. Kratz, "Determination of Betablockers and b-Sympathomimetics in the Aquatic Environment", Vom Wasser, 87:263-274 (1996).
14. Hirsch, R., T.A. Ternes, K. Haberer, and K.L. Kratz, "Occurrence of Antibiotics in the Aquatic Environmental", Sci. Total Environ., 225:109-118 (1999).
15. Hirsch, R., T.A. Ternes, K. Haberer, A. Mehlich, F. Ballwanz, and K.L. Kratz, "Determination of Antibiotics in Different Water Compartments via Liquid Chromatography - Electrospray Tandem Mass Spectrometry", J. Chromatogr. A, 815:213-223 (1998).
16. Hofmann, J., U. Freier, M. Wecks, and S. Hofmann, Degradation of Diclofenac in Water by Heterogeneous Catalytic Oxidation with H2O2", Appl. Catal.: B Environ., 70:447-451 (2007).
17. Huber, M.M., A. Gobel, A. Joss, N. Hermann, D. Loffler, C.S. Mcardell, A. Ried, H. Siegrist, T.A. Ternes, and U. von Gunten, "Oxidation of Pharmaceuticals During Ozonation of Municipal Wastewater Effluents: A Pilot Study", Environ. Sci. Technol., 39:4290-4299 (2005).
18. Huber, M.M., S. Canonica, G.Y. Park, and U. Von Gunten, "Oxidation of Pharmaceuticals During Ozonation and Advanced Oxidation Processes", Environ. Sci. Technol., 37:1016-1024 (2003).
19. Jones, O.A.H., N. Voulvoulis, and J.N. Lester, "Aquatic Environmental Assessment of the Top 25 English Prescription Pharmaceuticals," Water Res., 36:5013-5022 (2002).
20. Kopin, D. W., E.T. Furlong, M.T. Meyer, E.M. Thuman, S.D. Zaugg, L.B. Barber, and H.T. Buxton, "Pharmaceuticals, Hormones, and Other Organic Water Contaminants in U.S., Streams. 1999-2000: A National Reconnaissance", Environ. Sci. Technol., 36:1202 (2002).
21. Lindqvist, N., T. Tuhkanen, and L. Kronberg, "Occurrence of Acid Pharmaceuticals in Raw and Treated Sewages and in Receiving Waters", Water Res., 39:2219-2228 (2005).
22. Lopez A., G. Ricco G. Mascolo G. Tiravanti, A.C. Di Pinto, and R. Passino, "Biodegradability Enhancement of Refractory Pollutants by Ozonation: A Laboratory Investigation on an Azo-dyes Intermediate". Water Sci. Technol., 38:239-245 (1998).
23. Metcalf and Eddy. "Wastewater Engineering-Treatment, Disposal, and Reuse", International Ed., McGraw-Hill, New York (1991).
24. OECD, Guidelines for Testing of Chemicals, Test 302B, Vol. 2, Paris, France, 1996.
25. Perez-Estrada, L.A., M.I. Maldonado, W. Gernjak, A. Aguera, A. R. Fernandez-Alba, M.M. Ballesteros, and S. Malato, "Decomposition of Diclofenac by Solar Driven Photocatalysis at Pilot Scale", Catal. Today, 101: 219-226 (2005).
26. Roberts, P.H. and K.V. Thomas, "The Occurrence of Selected Pharmaceuticals in Wastewater Effluent and Surface Waters of the Lower Tyne Catchment", Sci. Total Environ., 356:143-153 (2006)
27. Schwaiger, J., H. Ferling, U. Mallow, H. Wintermayr, and R.D. Negele, "Toxic Effects of the Non-steroidal Anti-inflammatory Drug Diclofenac", Aquat. Tox., 68:141-150 (2004).
28. Standard Methods for the Examination of Water and Wastewater, 21st ed., American Public Health Association/American Water Works Association/Water Pollution Control Federation, Washington DC, USA, 2005.
29. Stumpf, M., T.A. Ternes, R. Wilken, S.V. Rodrigues, and W. Baumann, "Polar Drug Residues in Sewage and Natural Waters in the State of Rio de Janeiro, Brazil", Sci. Total Environ., 225:135-141 (1999).
30. Ternes, T.A., J. Stuber, N. Herrmann, D. Mcdowell, A. Ried, M. Kampmann, and B. Teiser, "Ozonation: A Tool for Removal of Pharmaceuticals, Contrast Media and Musk Fragrances from Wasterwater?", Water Res., 37:1976-1982 (2003).
31. Ternes, T.A., Occurrence of Drugs in German Sewage Treatment Plants and Rivers", Water Res., 32:3245-3260 (1998).
32. Ternes, T.A., P. Kreckel, and J. Mueller, Behaviour and occurrence of estrogens in municipal sewage treatment plants-I. Investigations in Germany, Canada and Brazil, Sci. Total Environ. 225:81-90 (1999).
33. Ternes, T.A., P. Kreckel, and J. Mueller, "Behaviour and Occurrence of Estrogens in Municipal Sewage Treatment Plants - II. Aerobic Batch Experiments with Activated Sludge", Sci. Total Environ., 225:91-99 (1999).
34. Thomas, K.V. and M.J. Hilton, "The Occurrence of Selected Human Pharmaceutical Compounds in UK Estuaries", Marine Pollution Bulletin, 49:436-444 (2004).
35. Tixier, T.A., H.P. Singer, S. Oellers, and S.R. Muller, "Occurrence and Fate of Carbamazepine, Ibuprofen, Ketoprofen and Naproxen in Surface Waters", Environ. Sci. Technol., 37:1061-1068 (2003).
36. Vogna, D., R. Marotta, A. Napolitano, R. Andreozzi, and M. D'ischia, "Advanced Oxidation of the Pharmaceutical Drug Diclofenac with UV/H2O2 and Ozone:, Water Res., 38:414-422 (2004).
37. Zuccato, E., S. Castiglioni, and R. Fanelli, "Identification of the Pharmaceuticals for Human Use Contaminating the Italian Aquatic Environment", J. Hazard. Mater., 122:205-209 (2005).
38. Zwiener, C. and F.H. Frimmel, "Oxidative Treatment of Pharmaceuticals in Water", Water Res., 34(6):1881-1885 (1999).